Neurodegenerative diseases-Caps: a capsule network based early screening system for the classification of neurodegenerative diseases

被引:0
|
作者
Kirti Raj Bhatele
Anand Jha
Kavish Kapoor
Devanshu Tiwari
机构
[1] RJIT,
[2] BSF Academy,undefined
[3] Kavlabs,undefined
[4] RGPV,undefined
来源
Cognitive Neurodynamics | 2022年 / 16卷
关键词
Neurodegenerative diseases; Parkinson; Alzheimer; Capsule network; ResNet50; VGG 16; VGG 19; InceptionV3 etc.;
D O I
暂无
中图分类号
学科分类号
摘要
The two most generally diagnosed Neurodegenerative diseases are the Alzheimer and Parkinson diseases. So this paper presents a fully automated early screening system based on the Capsule network for the classification of these two Neurodegenerative diseases. In this study, we hypothesized that the Neurodegenerative diseases-Caps system based on the Capsule network architecture accurately performs the multiclass i.e. three class classification into either the Alzheimer class or Parkinson class or Healthy control and delivers better results in comparison other deep transfer learning models. The real motivation behind choosing the capsule network architecture is its more resilient nature towards the affine transformations as well as rotational & translational invariance, which commonly persists in the medical image datasets. Apart from this, the capsule networks overcomes the pooling layers related deficiencies from which conventional CNNs are mostly affected and unable to delivers accurate results especially in the tasks related to image classification. The various Computer aided systems based on machine learning for the classification of brain tumors and other types of cancers are already available. Whereas for the classification of Neurodegenerative diseases, the amount of research done is very limited and the number of persons suffering from this type of diseases are increasing especially in developing countries like India, China etc. So there is a need to develop an early screening system for the correct multiclass classification into Alzheimer’s, Parkinson’s and Normal or Healthy control cases. The Alzheimer disease and Parkinson progression (ADPP) dataset is used in this research study for the training of the proposed Neurodegenerative diseases-Caps system. This ADPP dataset is developed with the aid of both the Parkinson's Progression Markers Initiative (PPMI) and Alzheimer’s disease Neuroimaging Initiative (ADNI) databases. There is no such early screening system exist yet, which can perform the accurate classification of these two Neurodegenerative diseases. For the sake of genuine comparison, other popular deep transfer learning models like VGG19, VGG16, ResNet50 and InceptionV3 are implemented and also trained over the same ADPP dataset. The proposed Neurodegenerative diseases-Caps system deliver accuracies of 97.81, 98, 96.81% for the Alzheimer, Parkinson and Healthy control or Normal cases with 70/30 (training/validation split) and performs way better as compare to the other popular Deep transfer learning models.
引用
收藏
页码:1361 / 1377
页数:16
相关论文
共 50 条
  • [21] Neurodegenerative diseases early detection and monitoring system for point-of-care applications
    Thakur, Rajiv
    Saini, Anil Kumar
    Taliyan, Rajeev
    Chaturvedi, Nidhi
    MICROCHEMICAL JOURNAL, 2025, 208
  • [22] miRNAs in neurodegenerative diseases: from target screening to precision therapy
    Liao, Dongyi
    Zhang, Yujie
    Li, Shuangyang
    Tang, Hongmei
    Bai, Xue
    NEUROLOGICAL SCIENCES, 2025,
  • [23] Screening of innate immune receptors in neurodegenerative diseases: A similar pattern
    Letiembre, Maryse
    Liu, Yang
    Walter, Silke
    Hao, Wenlin
    Pfander, Tatjana
    Wrede, Arne
    Schulz-Schaeffer, Walter
    Fassbender, Klaus
    NEUROBIOLOGY OF AGING, 2009, 30 (05) : 759 - 768
  • [24] Cholinergic System Dysfunction and Neurodegenerative Diseases: Cause or Effect?
    Tata, Ada M.
    Velluto, Lucia
    D'Angelo, Chiara
    Reale, Marcella
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (07) : 1294 - 1303
  • [25] Caenorhabditis elegans as a model system for target identification and drug screening against neurodegenerative diseases
    Ma, Liang
    Zhao, Yudan
    Chen, Yuchen
    Cheng, Biao
    Peng, Anlin
    Huang, Kun
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 819 : 169 - 180
  • [26] Failure of Ubiquitin Proteasome System: Risk for Neurodegenerative Diseases
    Zheng, Chen
    Geetha, Thangiah
    Babu, Jeganathan Ramesh
    NEURODEGENERATIVE DISEASES, 2014, 14 (04) : 161 - 175
  • [27] Discovery of new epigenomics-based biomarkers and the early diagnosis of neurodegenerative diseases
    Lee, Davin
    Choi, Yoon Ha
    Seo, Jinsoo
    Kim, Jong Kyoung
    Lee, Sung Bae
    AGEING RESEARCH REVIEWS, 2020, 61
  • [28] Links among glaucoma, neurodegenerative, and vascular diseases of the central nervous system
    Nucci, Carlo
    Martucci, Alessio
    Cesareo, Massimo
    Garaci, Francesco
    Morrone, Luigi Antonio
    Russo, Rossella
    Corasaniti, Maria Tiziana
    Bagetta, Giacinto
    Mancino, Raffaele
    NEW TRENDS IN BASIC AND CLINICAL RESEARCH OF GLAUCOMA: A NEURODEGENERATIVE DISEASE OF THE VISUAL SYSTEM, PT B, 2015, 221 : 49 - 65
  • [29] Classification of Neurodegenerative Diseases Based on VGG 19 Deep Transfer Learning Architecture: A Deep Learning Approach
    Bhatele, Kirti Raj
    Bhadauria, Sarita Singh
    BIOSCIENCE BIOTECHNOLOGY RESEARCH COMMUNICATIONS, 2020, 13 (04): : 1972 - 1980
  • [30] Preclinical Nanomedicines for Polyglutamine-Based Neurodegenerative Diseases
    Lee, Leo Kit Cheung
    Leong, Lok, I
    Liu, Yao
    Luo, Meihua
    Chan, Ho Yin Edwin
    Choi, Chung Hang Jonathan
    MOLECULAR PHARMACEUTICS, 2021, 18 (02) : 610 - 626